| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Net Common Stock Issuance | $528.86M | $300.42M | $128.09M | $143.71M | $462.90M |
| Proceeds from Stock Option Exercised | $4.09M | $8.14M | $12.81M | $10.72M | $8.44M |
| Net Other Financing Charges | -$3.00M | – | – | – | – |
| Ending Cash Balance | $753.92M | $603.02M | $401.43M | $559.11M | $295.35M |
| Net Change in Cash | $132.85M | $205.01M | -$157.88M | $264.07M | $28.18M |
| Beginning Cash Balance | $603.02M | $401.43M | $559.11M | $295.35M | $267.17M |
| Effect of Exchange Rate Changes | $18.04M | -$3.41M | $188,000.00 | -$307,000.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | $521.53M | $304.12M | $140.13M | $154.35M | $458.54M |
| Financing Cash Flow | $521.53M | $304.12M | $140.13M | $154.35M | $458.54M |
| Net Investment Purchase and Sale | -$3.81M | $0.00 | $480,000.00 | $230.61M | -$231.95M |
| Net Business Purchase and Sale | -$4.44M | $277.10M | $1.84M | $0.00 | $0.00 |
| Net Intangibles Purchase and Sale | -$2.16M | -$3.35M | -$597,000.00 | -$300,000.00 | $0.00 |
| Net PPE Purchase and Sale | -$6.47M | -$13.70M | -$11.96M | -$37.06M | -$39.80M |
| Net Cash Flow from Continuing Investing Activities | -$16.87M | $260.06M | -$10.23M | $193.25M | -$271.74M |
| -Change In Other Working Capital | -$36.77M | -$28.04M | -$41.08M | $110.32M | -$10.00M |
| Free Cash Flow | -$380.44M | -$376.22M | -$300.33M | -$120.88M | -$198.41M |
| -Change in Other Current Liabilities | -$19.99M | -$15.58M | -$9.86M | -$7.11M | $0.00 |
| -Change in Payables and Accrued Expense | -$12.35M | $11.69M | $8.44M | $1.71M | $15.07M |
| -Change in Prepaid Assets | $49.86M | -$8.76M | $6.00M | – | – |
| -Change in Receivables | $32.94M | -$6.07M | -$7.76M | -$2,000.00 | -$5.38M |
| Change in Working Capital | $13.69M | -$46.76M | -$44.26M | $104.92M | -$306,000.00 |
| Other Non-Cash Items | $53.88M | $32.96M | $5.45M | $8.56M | $4.10M |
| Depreciation & Depletion & Amortization | $83.70M | $36.49M | $24.40M | $11.76M | $8.41M |
| Gain/Loss from Continuing Operations | $4.50M | – | – | – | $827,000.00 |
| Net Income from Continuing Operations | -$644.76M | -$463.66M | -$328.07M | -$239.48M | -$186.48M |
| Net cash flow from continuing operations | -$371.81M | -$359.17M | -$287.78M | -$83.52M | -$158.61M |
| Operating Cash Flow | -$371.81M | -$359.17M | -$287.78M | -$83.52M | -$158.61M |
| Net cash flow from investing | -$16.87M | $260.06M | -$10.23M | $193.25M | -$271.74M |
| Net Issuance Payments Of Debt | -$8.43M | -$4.44M | -$766,000.00 | -$90,000.00 | -$12.80M |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| -Goodwill | $162.16M | $148.87M | $52.06M | $801,000.00 | $801,000.00 |
| Goodwill and Other Intangible Assets | $472.06M | $484.73M | $88.50M | $2.11M | $2.19M |
| -Accumulated Depreciation | -$89.21M | -$62.67M | -$44.87M | -$30.12M | -$18.74M |
| -Gross PPE | $258.69M | $295.88M | $165.05M | $151.56M | $83.46M |
| Net PPE | $169.48M | $233.21M | $120.17M | $121.45M | $64.73M |
| Other Current Assets | $28.57M | $38.11M | $40.25M | $15.87M | $7.51M |
| Restricted Cash | $4.59M | $3.05M | $3.23M | $1.28M | $1.55M |
| Prepaid Assets | $11.74M | $29.60M | – | – | – |
| -Other Receivables | $24.65M | $49.17M | $3.09M | $2.75M | $9.06M |
| Receivables | $24.65M | $49.17M | $3.09M | $2.75M | $9.09M |
| -Cash and Cash Equivalents | $743.29M | $594.35M | $391.57M | $549.91M | $285.12M |
| Cash and Cash Equivalents & Short-Term Investments | $743.29M | $594.35M | $391.57M | $549.91M | $516.56M |
| Total Current Assets | $812.85M | $714.27M | $438.14M | $569.81M | $534.72M |
| Total Assets | $1.47B | $1.45B | $653.70M | $701.29M | $610.35M |
| Non-Current Deferred Assets | $957,000.00 | $1.93M | $0.00 | – | – |
| Total Non-Current Assets | $661.29M | $734.33M | $215.56M | $131.47M | $75.63M |
| -Current Debt | $9.09M | $8.43M | $41,000.00 | $97,000.00 | $90,000.00 |
| -Other Intangible Assets | $309.90M | $335.86M | $36.44M | $1.31M | $1.39M |
| Gains/Losses Not Affecting Retained Earnings | $36.72M | -$7.64M | $0.00 | – | -$126,000.00 |
| Other Non-Current Assets | $18.79M | $14.45M | $6.89M | $7.92M | $8.72M |
| Stockholders' Equity | $1.13B | $1.03B | $463.44M | $485.81M | $542.94M |
| Total Equity | $1.13B | $1.03B | $463.44M | $485.81M | $542.94M |
| Other Non-Current Liabilities | $2.08M | $4.73M | – | – | – |
| Non-Current Deferred Liabilities | $137.27M | $135.34M | $52.58M | $70.26M | $10.78M |
| -Long Term Debt | $9.56M | $19.02M | $1.10M | $536,000.00 | $633,000.00 |
| Long Term Debt and Capital Lease Obligation | $56.21M | $86.27M | $44.52M | $44.96M | $9.97M |
| Total Non-Current Liabilities | $195.56M | $226.34M | $97.09M | $115.22M | $20.75M |
| Current Deferred Liabilities | $37.61M | $61.77M | $36.43M | $56.73M | $10.00M |
| -Current Capital Lease Obligation | $12.66M | $13.80M | $6.12M | $5.95M | $1.42M |
| Short-Term Debt and Capital Lease Obligation | $21.75M | $22.22M | $6.16M | $6.05M | $1.51M |
| Current Accrued Expenses | $38.46M | $31.02M | $23.75M | $12.47M | $20.60M |
| Payables | $18.12M | $21.61M | $3.95M | $4.59M | $2.82M |
| Total Current Liabilities | $147.71M | $187.47M | $93.17M | $100.27M | $46.66M |
| Total Liabilities | $343.27M | $413.82M | $190.26M | $215.48M | $67.41M |
| Capital Stock | $5,000.00 | $4,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Common Stock | $5,000.00 | $4,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| Retained Earnings | -$2.08B | -$1.43B | -$967.62M | -$639.56M | -$400.08M |
| -Accounts Payable | $18.12M | $21.61M | $3.95M | $4.59M | $2.82M |
| Additional Paid-In Capital | $3.17B | $2.47B | $1.43B | $1.13B | $943.14M |
| -Long Term Capital Lease Obligation | $46.65M | $67.25M | $43.41M | $44.42M | $9.34M |
| -Short Term Investments | – | – | – | – | $231.45M |
| -Accounts Receivable | – | – | – | – | $34,000.00 |
No comments yet — be the first to weigh in on RXRX.